Masayuki Tahara

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial

Masayuki Tahara, Tomoko Oeda, Kazumasa Okada et al. · The Lancet Neurology · 2020 · 368 citations

Medicine, Clinical Sciences, Neurology +5

Surgical repair of postinfarction ventricular septal defect.

Masayuki Tahara · Japanese Journal of Cardiovascular Surgery · 1990 · 65 citations · Full text

Medicine, Cardiology, Surgery +16

Factors related to physical functioning decline after cardiac surgery in older patients: A multicenter retrospective study

Atsunori Itagaki, Masakazu Saitoh, Daisuke Okamura et al. · Journal of Cardiology · 2019 · 37 citations · Full text

Medicine, Cardiology, Surgery +17

Impact of preoperative frailty on regaining walking ability in patients after cardiac surgery: Multicenter cohort study in Japan

Satoshi Yuguchi, Masakazu Saitoh, Keisuke Oura et al. · Archives of Gerontology and Geriatrics · 2019 · 35 citations

Medicine, Cardiology, Perioperative Medicine +16

Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration

Masayuki Tahara, Tomoko Oeda, Kazumasa Okada et al. · Multiple Sclerosis and Related Disorders · 2022 · 29 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14